Cidara Therapeutics’ CD388 Receives FDA Breakthrou...
Category : ODD/BTA/FTA Status 13 October 2025Cidara Therapeutics announced that the U.S. FDA has granted Breakthrough Therapy designation for CD3...
Odd Bta Fta Status
Japan’s MHLW grants orphan drug designation to Vic...
Category : ODD/BTA/FTA Status 3 October 2025"Vicore Pharma Holding AB, unlocking the potential of a novel class of drugs, angiotensin II ty...
Clear Scientific’s CS-1103 Receives FDA Fast Track...
Category : ODD/BTA/FTA Status 1 October 2025Clear Scientific Inc., a clinical-stage biopharmaceutical company, announced today that the U.S. Foo...
Teva’s Emrusolmin Receives U.S. FDA Fast Track Des...
Category : ODD/BTA/FTA Status 12 September 2025"Teva Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has grante...
Keros Therapeutics Secures Orphan Drug Designation...
Category : ODD/BTA/FTA Status 25 August 2025Keros Therapeutics just earned a major regulatory win: the U.S. FDA has granted Orphan Drug designat...
Latest Newsletter Post
-
FDA Clears First ACL Implant Label..
19 January 2026
-
Boston Scientific to Acquire Penumb..
19 January 2026
-
Diabeloop and Sequel Med Tech Partn..
19 January 2026
-
Zylox-Tonbridge to Acquire Germany’..
19 January 2026
-
Brenig Therapeutics Advances Two CN..
16 January 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com